Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FRUIT-RCT follow-up study of aspirin resistance and cardiovascular risk after recurrent hypertensive disorders of pregnancy
NL-OMON41727Not yet recruiting
- Sponsor
- VU University Medical Center
- Start
- Apr 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of aspirin in maternal hypertension (HDP) and preeclampsia (2 arms), sponsored by VU University Medical Center. Primary endpoints: Aspirin resistance and Cardiovascular risk factors. Planned start Apr 2015; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
maternal hypertension (HDP)preeclampsia
Beyond the preview
Go deeper on NL-OMON41727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41727.